175 related articles for article (PubMed ID: 25858130)
1. Chlorotoxin-conjugated nanoparticles for targeted imaging and therapy of glioma.
Zhao L; Shi X; Zhao J
Curr Top Med Chem; 2015; 15(13):1196-208. PubMed ID: 25858130
[TBL] [Abstract][Full Text] [Related]
2. Chlorotoxin labeled magnetic nanovectors for targeted gene delivery to glioma.
Kievit FM; Veiseh O; Fang C; Bhattarai N; Lee D; Ellenbogen RG; Zhang M
ACS Nano; 2010 Aug; 4(8):4587-94. PubMed ID: 20731441
[TBL] [Abstract][Full Text] [Related]
3. Time-Resolved MRI Assessment of Convection-Enhanced Delivery by Targeted and Nontargeted Nanoparticles in a Human Glioblastoma Mouse Model.
Stephen ZR; Chiarelli PA; Revia RA; Wang K; Kievit F; Dayringer C; Jeon M; Ellenbogen R; Zhang M
Cancer Res; 2019 Sep; 79(18):4776-4786. PubMed ID: 31331912
[TBL] [Abstract][Full Text] [Related]
4. Chlorotoxin-conjugated nanoparticles as potential glioma-targeted drugs.
Fu Y; An N; Li K; Zheng Y; Liang A
J Neurooncol; 2012 May; 107(3):457-62. PubMed ID: 22108716
[TBL] [Abstract][Full Text] [Related]
5. Chlorotoxin modified morusin-PLGA nanoparticles for targeted glioblastoma therapy.
Agarwal S; Mohamed MS; Mizuki T; Maekawa T; Sakthi Kumar D
J Mater Chem B; 2019 Oct; 7(39):5896-5919. PubMed ID: 31423502
[TBL] [Abstract][Full Text] [Related]
6. Anti-gliomas Effect of Chlorotoxin-Conjugated Onconase at High Dose.
Wang X; Guo Z
Cell Biochem Biophys; 2015 Nov; 73(2):389-392. PubMed ID: 27352327
[TBL] [Abstract][Full Text] [Related]
7. Targeted delivery of chlorotoxin-modified DNA-loaded nanoparticles to glioma via intravenous administration.
Huang R; Ke W; Han L; Li J; Liu S; Jiang C
Biomaterials; 2011 Mar; 32(9):2399-406. PubMed ID: 21185076
[TBL] [Abstract][Full Text] [Related]
8. Development of the research on the application of chlorotoxin in imaging diagnostics and targeted therapies for tumors.
Wu XS; Jian XC; Yin B; He ZJ
Chin J Cancer; 2010 Jun; 29(6):626-30. PubMed ID: 20507737
[TBL] [Abstract][Full Text] [Related]
9. Chlorotoxin-conjugated graphene oxide for targeted delivery of an anticancer drug.
Wang H; Gu W; Xiao N; Ye L; Xu Q
Int J Nanomedicine; 2014; 9():1433-42. PubMed ID: 24672236
[TBL] [Abstract][Full Text] [Related]
10. Identification of two novel Chlorotoxin derivatives CA4 and CTX-23 with chemotherapeutic and anti-angiogenic potential.
Xu T; Fan Z; Li W; Dietel B; Wu Y; Beckmann MW; Wrosch JK; Buchfelder M; Eyupoglu IY; Cao Z; Savaskan NE
Sci Rep; 2016 Feb; 6():19799. PubMed ID: 26831010
[TBL] [Abstract][Full Text] [Related]
11. Stable and efficient Paclitaxel nanoparticles for targeted glioblastoma therapy.
Mu Q; Jeon M; Hsiao MH; Patton VK; Wang K; Press OW; Zhang M
Adv Healthc Mater; 2015 Jun; 4(8):1236-45. PubMed ID: 25761648
[TBL] [Abstract][Full Text] [Related]
12. Optical and MRI multifunctional nanoprobe for targeting gliomas.
Veiseh O; Sun C; Gunn J; Kohler N; Gabikian P; Lee D; Bhattarai N; Ellenbogen R; Sze R; Hallahan A; Olson J; Zhang M
Nano Lett; 2005 Jun; 5(6):1003-8. PubMed ID: 15943433
[TBL] [Abstract][Full Text] [Related]
13. Targeted diazeniumdiolates: localized nitric oxide release from glioma-specific peptides and proteins.
Safdar S; Taite LJ
Int J Pharm; 2012 Jan; 422(1-2):264-70. PubMed ID: 22101282
[TBL] [Abstract][Full Text] [Related]
14. Functionalized magnetic nanochains with enhanced MR imaging: A novel nanosystem for targeting and inhibition of early glioma.
Zhang Y; Huang Z; Wu Z; Yin G; Wang L; Gao F
Colloids Surf B Biointerfaces; 2016 Apr; 140():437-445. PubMed ID: 26803007
[TBL] [Abstract][Full Text] [Related]
15. RVG29-modified docetaxel-loaded nanoparticles for brain-targeted glioma therapy.
Hua H; Zhang X; Mu H; Meng Q; Jiang Y; Wang Y; Lu X; Wang A; Liu S; Zhang Y; Wan Z; Sun K
Int J Pharm; 2018 May; 543(1-2):179-189. PubMed ID: 29555442
[TBL] [Abstract][Full Text] [Related]
16. Targeted nitric oxide delivery preferentially induces glioma cell chemosensitivity via altered p53 and O(6) -methylguanine-DNA methyltransferase activity.
Safdar S; Payne CA; Tu NH; Taite LJ
Biotechnol Bioeng; 2013 Apr; 110(4):1211-20. PubMed ID: 23125026
[TBL] [Abstract][Full Text] [Related]
17. CTX-CNF1 Recombinant Protein Selectively Targets Glioma Cells In Vivo.
Vannini E; Mori E; Tantillo E; Schmidt G; Caleo M; Costa M
Toxins (Basel); 2021 Mar; 13(3):. PubMed ID: 33800135
[TBL] [Abstract][Full Text] [Related]
18. OX26/CTX-conjugated PEGylated liposome as a dual-targeting gene delivery system for brain glioma.
Yue PJ; He L; Qiu SW; Li Y; Liao YJ; Li XP; Xie D; Peng Y
Mol Cancer; 2014 Aug; 13():191. PubMed ID: 25128329
[TBL] [Abstract][Full Text] [Related]
19. New Perspectives in Glioblastoma: Nanoparticles-based Approaches.
Luciano R; Battafarano G; Saracino R; Rossi M; Perrotta A; Manco M; Muraca M; Del Fattore A
Curr Cancer Drug Targets; 2017; 17(3):203-220. PubMed ID: 27528362
[TBL] [Abstract][Full Text] [Related]
20. Doxorubicin-loaded nanoparticles consisted of cationic- and mannose-modified-albumins for dual-targeting in brain tumors.
Byeon HJ; Thao le Q; Lee S; Min SY; Lee ES; Shin BS; Choi HG; Youn YS
J Control Release; 2016 Mar; 225():301-13. PubMed ID: 26826308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
